2005•Zhōnghuá yàoxué zázhìRequires access

Study on pharmacokinetics of nimodipine polymorphs in rabbits

Yuan Heng-jie

Open publisher page 0 citations

Abstract

OBJECTIVE To study pharmacokinetics and relative bioavailability of nimodipine polymorphs in rabbits.METHODS According to the crossover design, each rabbit was orally given nimodipine polymorph capsules. The plasma concentrations were determined by HPLC. Pharmacokinetic parameters were calculated. The analysis of variance and two-one sided t test were used as statistical analysis.RESULTS After a single oral dose, Cmax were 46.70 and 39.64 ng·mL-1, tmax were 2.8 and 3.0 h, AUC0→t were 351.5 and 341.0 ng·h·mL-1 for nimodipine Ⅰ and Ⅱ.respectively. The relative bioavailability of nimodipine polymorphⅡ was 97.0% compared with Ⅰ . CONCLUSION Nimodipine polymorphs were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To study pharmacokinetics and relative bioavailability of nimodipine polymorphs in rabbits.METHODS According to the crossover design, each rabbit was orally given nimodipine polymorph capsules. The plasma concentrations were determined by HPLC. Pharmacokinetic parameters were calculated. The analysis of variance and two-one sided t test were used as statistical analysis.RESULTS After a single oral dose, Cmax were 46.70 and 39.64 ng·mL-1, tmax were 2.8 and 3.0 h, AUC0→t were 351.5 and 341.0 ng·h·mL-1 for nimodipine Ⅰ and Ⅱ.respectively. The relative bioavailability of nimodipine polymorphⅡ was 97.0% compared with Ⅰ . CONCLUSION Nimodipine polymorphs were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study pharmacokinetics and relative bioavailability of nimodipine polymorphs in rabbits.METHODS According to the crossover design, each rabbit was orally given nimodipine polymorph capsules. The plasma concentrations were determined by HPLC. Pharmacokinetic parameters were calculated. The analysis of variance and two-one sided t test were used as statistical analysis.RESULTS After a single oral dose, Cmax were 46.70 and 39.64 ng·mL-1, tmax were 2.8 and 3.0 h, AUC0→t were 351.5 and 341.0 ng·h·mL-1 for nimodipine Ⅰ and Ⅱ.respectively. The relative bioavailability of nimodipine polymorphⅡ was 97.0% compared with Ⅰ . CONCLUSION Nimodipine polymorphs were bioequivalent.

Key concepts: Nimodipine, Bioequivalence, Bioavailability, Pharmacokinetics, Cmax, Crossover study, Pharmacology, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on pharmacokinetics of nimodipine polymorphs in rabbits — Research Paper | ScholarLens